|Bid||127.85 x 100|
|Ask||131.99 x 100|
|Day's Range||128.14 - 130.73|
|52 Week Range||96.93 - 139.00|
|PE Ratio (TTM)||48.93|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Technology stocks led the S&P 500 on Tuesday, but in exchange-traded fund land, those tracking biotech stocks were the real winners. The SPDR S&P Biotech ETF (XBI) and First Trust NYSE Arca Biotechnology ...
Regeneron Pharmaceuticals has a slew of clinical trials going on, and studies evaluating REGN-2810 could be the most important.
You don't need to take on a ton of risk to be a growth investor.